Assessing low-frequency oscillations in cerebrovascular diseases and related conditions with near-infrared spectroscopy: A plausible method for evaluating cerebral autoregulation?

被引：12
作者：
Andersen A.V. [1 ,2 ]
Simonsen S.A. [1 ,2 ]
Schytz H.W. [1 ,2 ]
Iversen H.K. [1 ,2 ]
机构：
[1] Rigshospitalet Department of Neurology, Glostrup
[2] University of Copenhagen, Department of Clinical Medicine, Copenhagen
来源：
Neurophotonics | 2018年 / 5卷 / 03期
关键词：
cerebral autoregulation; cerebrovascular diseases; low-frequency oscillations; near-infrared spectroscopy; risk of stroke;
D O I：
10.1117/1.NPh.5.3.030901
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Cerebral autoregulation (CA) is the brain's ability to always maintain an adequate and relatively constant blood supply, which is often impaired in cerebrovascular diseases. Near-infrared spectroscopy (NIRS) examines oxygenated hemoglobin (OxyHb) in the cerebral cortex. Low- and very low-frequency oscillations (LFOs 0.1 Hz and VLFOs 0.05 to 0.01 Hz) in OxyHb have been proposed to reflect CA. Aim: To systematically review published results on OxyHb LFOs and VLFOs in cerebrovascular diseases and related conditions measured with NIRS. Approach: A systematic search was performed in the MEDLINE database, which generated 36 studies relevant for inclusion. Results: Healthy people have relatively stable LFOs. LFO amplitude seems to reflect myogenic CA being decreased by vasomotor paralysis in stroke, by smooth muscle damage or as compensatory action in other conditions but can also be influenced by the sympathetic tone. VLFO amplitude is believed to reflect neurogenic and metabolic CA and is lower in stroke, atherosclerosis, and with aging. Both LFO and VLFO synchronizations appear disturbed in stroke, while the former is also altered in internal carotid stenosis and hypertension. Conclusion: We conclude that amplitudes of LFOs and VLFOs are relatively robust measures for evaluating mechanisms of CA and synchronization analyses can show temporal disruption of CA. Further research and more coherent methodologies are needed. © The Authors 2018.
引用
收藏
相关论文
共 145 条
[1]  
Paulson O.B., Strandgaard S., Edvinsson L., Cerebral autoregulation, Cerebrovasc. Brain Metab. Rev., 2, 2, pp. 161-192, (1990)
[2]  
Donnelly J., Aries M.J., Czosnyka M., Further understanding of cerebral autoregulation at the bedside: Possible implications for future therapy, Expert Rev. Neurother., 15, pp. 169-185, (2015)
[3]  
Lassen N.A., Cerebral blood flow and oxygen consumption in man, Physiol. Rev., 39, pp. 183-238, (1959)
[4]  
Faraci F.M., Heistad D.D., Regulation of large cerebral arteries and cerebral microvascular pressure, Circ. Res., 66, pp. 8-17, (1990)
[5]  
Moerman A., De Hert S., Recent advances in cerebral oximetry. Assessment of cerebral autoregulation with near-infrared spectroscopy: Myth or reality?, F1000Res., 6, (2017)
[6]  
Brady K.M., Et al., Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy, Stroke, 38, pp. 2818-2825, (2007)
[7]  
Chillon J.M., Baumbach G.L., Autoregulation of cerebral blood flow, Cerebrovascular Diseases, pp. 51-54, (1997)
[8]  
Folino A.F., Cerebral autoregulation and syncope, Prog. Cardiovasc. Dis., 50, pp. 49-80, (2007)
[9]  
Lassen N.A., Agnoli A., The upper limit of autoregulation of cerebral blood flow on the pathogenesis of hypertensive encephalopathy, Scand. J. Clin. Lab. Invest., 30, pp. 113-116, (1972)
[10]  
Phillips S.J., Whisnant J.P., Hypertension and the brain, Arch. Intern. Med., 152, pp. 938-945, (1992)
12345678910